In medico-legal contexts, functional neurological disorder (FND) is best understood as a disorder of nervous system functioning rather than a structural disease, with symptoms that are genuine, involuntary, and potentially disabling. The term “functional” is preferred over older labels such as “conversion disorder,” “psychogenic,” or “hysterical,” because it is more neutral, avoids implying that symptoms are imaginary, and aligns with contemporary neuroscience evidence. Legally, this distinction matters: courts and insurance decision-makers increasingly recognize FND as a legitimate neurological condition when it is diagnosed using positive clinical criteria and supported by appropriate documentation, rather than as a diagnosis of exclusion or a mere label for unexplained symptoms.
Modern diagnostic approaches emphasize the identification of positive, internally inconsistent, or incongruent neurological signs that are characteristic of FND, rather than relying only on the absence of structural pathology on MRI, CT, EEG, or laboratory tests. For example, in functional limb weakness, clinicians may elicit Hoover’s sign, give-way weakness, or a discrepancy between power on formal testing and observed function during informal tasks such as dressing or walking. In functional seizures (also termed dissociative seizures or psychogenic nonepileptic seizures, PNES), prolonged episodes with closed eyes, fluctuating course, asynchronous limb movements, or preserved awareness of the environment, when combined with normal ictal EEG during typical events, can support the diagnosis. Such positive findings show that symptoms are produced by disrupted brain networks and attention mechanisms, not by deliberate control, and they are central to reinforcing the diagnosis in legal and insurance settings.
Diagnostic systems used in legal proceedings, such as the DSM-5-TR and ICD-11, provide formal definitions that often serve as reference points in expert reports, court testimony, and disability determinations. Under DSM-5-TR, FND (functional neurological symptom disorder) requires: one or more symptoms of altered voluntary motor or sensory function; clinical evidence of incompatibility between the symptom and recognized neurological or medical conditions; symptoms not better explained by another medical or mental disorder; and symptoms causing clinically significant distress or impairment in social, occupational, or other important areas of functioning. ICD-11 classifies dissociative neurological symptom disorders and emphasizes the presence of positive signs of internal inconsistency or incongruence. These specific criteria can be mapped directly onto medico-legal questions such as causation, functional impact, and prognosis.
Because FND is a diagnosis that straddles neurology and psychiatry, a central medico-legal concern is whether it is approached as a primarily psychological disorder, a neurological disorder, or a condition that spans both domains. Contemporary evidence supports a biopsychosocial model in which biological vulnerability, life experiences, and immediate triggers converge on abnormal patterns of brain network functioning. Legally, it is important to clarify that the presence or absence of psychological trauma, stressors, or comorbid mental health conditions does not determine whether symptoms are “real” or fabricated. Many individuals with FND lack a clear precipitating stressor, and the disorder is not dependent on a history of abuse or overt psychological conflict. Misunderstanding these points can lead to inappropriate denial of benefits, unfair challenges to credibility, or erroneous conclusions in personal injury and occupational cases.
The concept of “functional” symptoms can sometimes be misconstrued in adversarial settings as implying that the person could control their symptoms if they chose to, or that symptoms are a form of malingering. Medico-legal definitions must therefore distinguish clearly among three entities: FND, factitious disorder, and malingering. In FND, symptoms are involuntary; the person experiences them as genuinely distressing and outside of their conscious control. In factitious disorder, symptoms are intentionally produced to adopt a sick role, even in the absence of clear external incentives. In malingering, symptoms are deliberately feigned or exaggerated for external gain such as financial compensation, avoidance of work, or legal advantage. Current research indicates that deliberate feigning is uncommon among people with well-characterized FND, and expert witnesses should emphasize that the presence of functional findings does not by itself imply deception.
From a legal perspective, a rigorously established diagnosis of FND can support claims related to disability, insurance coverage, or workplace accommodations when it is grounded in a systematic clinical evaluation. This typically includes a detailed history, neurological examination highlighting positive functional signs, appropriate investigations to exclude alternative diagnoses where indicated, and a clear explanation to the patient about the nature of the condition. The communication of the diagnosis is especially important: when individuals understand that their symptoms are real but potentially reversible, and that targeted therapies exist, they are more likely to engage in treatment and less likely to be viewed as uncooperative or resistant in medico-legal evaluations.
Diagnostic clarity in FND often depends on recognizing patterns of internal inconsistency over time and across contexts, such as fluctuating weakness, gait abnormalities that improve with distraction, or sensory loss with non-anatomical boundaries. In a courtroom or administrative setting, these features can be misinterpreted as evidence of fabrication if not properly explained. The legal relevance of these signs lies in the fact that they are reproducible, well-described in the neurological literature, and associated with characteristic brain network changes on advanced imaging studies. Expert witnesses must therefore translate technical concepts, such as incongruence with neuroanatomy or impairment of motor intention, into accessible language for judges, juries, and adjudicators.
The presence of comorbid conditions, such as epilepsy, multiple sclerosis, migraine, or psychiatric diagnoses, further complicates medico-legal definitions. Individuals can have both organic and functional symptoms concurrently, and one condition may overshadow the other. For instance, someone with epilepsy may also have functional seizures, or a person with peripheral neuropathy may develop superimposed functional sensory loss. In legal disputes, opposing experts may attempt to attribute all impairment to the structural disease or, conversely, to the functional diagnosis alone. A careful, nuanced assessment that separates and quantifies the contributions of each condition is critical for accurately determining causation, apportionment of liability, and appropriate levels of compensation or benefits.
Temporal relationships between events and symptom onset frequently drive medico-legal debates, particularly in personal injury, occupational, and medical negligence cases. FND may emerge in the aftermath of physical injury, surgery, a neurological event such as a transient ischemic attack, or psychological trauma. The law typically requires an analysis of whether the triggering event materially contributed to the development of the disorder, even if it did not cause structural damage. Expert opinion must outline plausible mechanisms—for example, how acute pain, heightened arousal, or threat-related attention to the body could interact with vulnerability factors to precipitate FND. This framework can help courts move beyond simplistic expectations that only visible structural injury can give rise to chronic neurological disability.
In many jurisdictions, medico-legal analysis also asks whether FND is stable, fluctuating, or potentially reversible with treatment, and how this should influence assessments of prognosis and long-term costs. Evidence indicates that early, accurate diagnosis combined with specialized physiotherapy, psychological therapies, and rehabilitation can improve outcomes, whereas delayed recognition, repeated unnecessary investigations, and adversarial disputes tend to worsen prognosis. When determining future care needs or the reasonableness of treatment plans, lawyers and insurers should take into account that appropriate multidisciplinary care is the recommended standard, and that failure to provide it may itself contribute to persistence of disability and associated expenses.
The standard of proof in civil medico-legal contexts is typically a “balance of probabilities,” meaning that a diagnosis of FND must be more likely than not, given the clinical data. Courts and administrative bodies often rely heavily on expert reports to determine whether this standard is met. High-quality reports detail the history, examination findings, and investigations; explicitly identify positive functional signs and how they meet DSM or ICD criteria; and explain differential diagnoses and reasons for favoring FND. They should also address functional impact on daily living, work capacity, and safety, but clearly differentiate between diagnostic certainty and predictions about future course, which necessarily involve some degree of uncertainty.
Language used in medical records can have significant medico-legal consequences for individuals with FND. Terms like “non-organic,” “psychogenic,” or “medically unexplained” may be interpreted by non-clinical readers as implying that symptoms are imaginary or feigned. Conversely, overly vague descriptions risk creating doubt about diagnostic rigor. Clinicians are therefore encouraged to use specific, evidence-based terminology—for example, “functional limb weakness characterized by Hoover’s sign and inconsistency with corticospinal lesion,” or “functional seizures confirmed by video-EEG with typical events and absence of epileptic activity.” Precise wording reduces misunderstanding by insurers, disability adjudicators, and courts, and serves as a safeguard against later mischaracterization of the condition.
In criminal and civil litigation, questions often arise about capacity, volition, and responsibility when FND symptoms intersect with behavior that has legal implications, such as driving incidents, workplace accidents, or alleged non-compliance with safety protocols. The medico-legal definition of FND underscores that symptoms such as sudden loss of motor control, non-epileptic seizures, or functional visual loss are experienced as involuntary. However, experts may still be asked to opine on whether the individual had prior warning signs, whether they had been advised to avoid certain activities, and whether they took reasonable steps to mitigate risk. Distinguishing the involuntary nature of symptoms from the person’s responsibilities once diagnosed—such as following medical advice not to drive after functional seizures—requires careful, case-specific analysis.
Independent medical examinations (IMEs) and second-opinion assessments play a prominent role in shaping medico-legal definitions in contested cases. The quality and neutrality of these evaluations vary widely. Best practice involves a comprehensive clinical interview, review of prior records, neurological examination with documentation of functional signs, and, where appropriate, neuropsychological or psychiatric consultation. Experts should clearly state the limitations of a single-time-point assessment and avoid overinterpreting minor inconsistencies as evidence of intentional deception. Particularly in FND, where fluctuations and context-dependent changes are part of the diagnosis, misunderstanding these patterns can lead to unjustified denial of claims or undermining of legitimate appeals.
Cultural and systemic factors also influence how FND is defined and interpreted in legal and insurance frameworks. In some systems, the absence of an identifiable lesion is still equated with absence of disease, whereas in others, functional disorders are explicitly recognized in guidelines and case law. The extent to which FND is listed in disability schedules, coverage policies, or official impairment rating guides can determine whether individuals receive appropriate support. Ongoing alignment of legal standards with contemporary neuroscientific and clinical understanding is therefore essential to prevent outdated stereotypes from shaping adjudication.
Ultimately, medico-legal definitions and diagnostic criteria for FND must balance scientific rigor with fairness to the affected individual. This requires rejecting simplistic binaries of “organic versus psychological,” grounding the diagnosis in positive evidence and established criteria, and clearly distinguishing FND from malingering or factitious disorder. When these principles are applied, FND can be reliably recognized as a genuine and potentially serious neurological condition, allowing legal systems, insurers, and disability programs to evaluate claims on a sound and consistent basis rather than on stigma or misunderstanding.
Disability benefits and eligibility assessments
Eligibility for disability benefits in the context of functional neurological disorder is often more closely tied to the assessment framework of the benefits system than to the clinical nuances of the diagnosis itself. Most schemes—whether social security programs, private disability insurance, or occupational pension arrangements—require a determination of functional impairment, not merely the presence of a medical condition. Consequently, claimants with FND must demonstrate how symptoms such as functional seizures, limb weakness, gait disturbance, tremor, functional cognitive symptoms, or sensory changes affect their capacity to carry out activities of daily living, sustain attention, and perform consistent, reliable work. The lack of structural abnormalities on imaging can be misinterpreted by assessors unfamiliar with FND as evidence against disability, making education and clear clinical explanation especially important.
Disability benefit systems generally distinguish between short-term incapacity, long-term or permanent disability, and partial versus total impairment. In FND, symptoms often fluctuate and may show potential for improvement with appropriate treatment, complicating these categorizations. Some individuals may have prolonged episodes of non-epileptic seizures or unpredictable collapses that preclude safe employment in safety-sensitive roles, even if their neurological examination is intermittently normal. Others may experience chronic fatigue, pain, or cognitive symptoms that limit endurance rather than absolute capacity. Assessors must therefore consider not only whether a person can perform a task once in an ideal setting but whether they can sustain that activity reliably, without unacceptable risk, over the course of a normal workday or workweek.
Different jurisdictions and insurers use varying standards for determining disability, such as “own occupation” versus “any occupation” tests. Under an “own occupation” standard, the question is whether FND symptoms prevent the person from performing the essential duties of their specific job, taking into account training, experience, and skills. A surgeon who develops functional tremor or a bus driver with frequent functional seizures may be considered disabled from their own occupation even if they could, in principle, perform sedentary, low-risk tasks. Under an “any occupation” standard, the focus shifts to whether the person can perform any reasonable work for which they are suited. In FND, this often raises contentious debates about transferrable skills, the feasibility of retraining, and the impact of fluctuating symptoms on attendance and performance in less demanding roles.
Functional assessments in disability evaluations frequently use structured tools, such as activities-of-daily-living scales, work capacity evaluations, or standardized questionnaires addressing mobility, self-care, cognition, communication, and social interaction. While such instruments can provide a framework, they may not fully capture the episodic and context-dependent features of FND. For example, an individual may be able to walk short distances during a scheduled assessment yet experience unpredictable episodes of complete leg weakness at home, leading to frequent falls. Or they may appear conversant and cognitively intact in a quiet examination room but struggle with information processing and concentration in busy, multi-tasking work environments. Assessors must therefore integrate self-report, collateral information from family or employers, and longitudinal records with the snapshot obtained during a single evaluation.
Thorough medical documentation is a cornerstone of successful disability claims for individuals with FND. Decision-makers often place particular weight on consistent, longitudinal records from treating clinicians that describe positive functional signs, the evolution of symptoms, responses to treatment, and the impact on everyday functioning. Records that specify, for example, “functional seizures diagnosed by neurologist with video-EEG confirmation, episodes occurring 3–4 times per week, associated post-event fatigue and cognitive slowing, advised not to drive” are more persuasive than vague references to “blackouts” or “spells.” Similarly, descriptions such as “functional gait disorder with marked variability, ability to walk with near-normal pattern when distracted, but frequent sudden collapses, requiring use of mobility aids and supervision for outdoor ambulation” help adjudicators understand why symptoms are disabling even when examination findings fluctuate.
Independent medical examinations commissioned by insurers or disability agencies can be particularly influential but are also a frequent source of dispute. Examiners unfamiliar with FND may misinterpret internal inconsistency on examination as deliberate feigning, leading to opinions that the claimant has no objective impairment. Best practice in such assessments involves explicitly identifying characteristic functional signs, acknowledging that inconsistency is part of the diagnosis, and addressing how these findings translate into real-world limitations. Examiners should avoid simplistic statements such as “normal MRI therefore no disability” and instead explain how a normal structural scan is compatible with a functional disorder that nonetheless impairs safety and reliability in the workplace.
Many disability determination systems require claimants to show that they are engaged in appropriate treatment and rehabilitation. For FND, this typically includes neurologist involvement, education about the diagnosis, and, where available, specialized physiotherapy, psychological therapies, or multidisciplinary rehabilitation. Non-engagement with treatment may be interpreted as evidence that the disability is not as severe as claimed, even when access barriers or prior negative experiences with healthcare have shaped the person’s attitudes. Clinicians can assist by documenting treatment recommendations, explaining delays or refusals where reasonable—for example, when waiting lists are long or prior therapies were ineffective—and clarifying that lack of full recovery does not equate to lack of effort.
Assessors may also ask whether symptoms are “permanent” or whether improvement is expected with treatment. Because prognosis in FND is heterogeneous, expert opinions should be cautious and individualized. Factors associated with better outcomes include early diagnosis, absence of major comorbidities, and access to specialized therapy, whereas long symptom duration, entrenched disability, and adversarial legal processes can worsen prognosis. In disability determinations, this uncertainty often translates into time-limited awards with planned reviews. Reports can help structure these reviews by specifying reasonable treatment milestones, anticipated time frames, and indicators of progress or deterioration, rather than making unrealistic predictions of full recovery or permanent total disability in all cases.
A recurrent issue in disability benefits and eligibility assessments is the treatment of coexisting physical or psychiatric conditions. Many individuals with FND have comorbid depression, anxiety, PTSD, chronic pain, or other neurologic or rheumatologic disorders. Decision-makers sometimes attempt to attribute all functional limitations to “mental health issues” or, conversely, to ignore psychological factors and focus only on the functional neurological diagnosis. A balanced analysis should describe how each condition contributes to the overall picture, whether interactions between them amplify disability, and whether benefit entitlement is linked to one primary diagnosis or to the combined effect of multiple impairments under relevant legal criteria.
Credibility assessments, although often implicit, play a prominent role in disability determinations for FND because the condition is poorly understood and lacks obvious structural markers. Decision-makers may place disproportionate emphasis on surveillance footage, social media activity, or isolated observations that show the individual functioning at a higher level than reported. Experts familiar with FND should explain that variability and context dependence are intrinsic features of the disorder and that occasional “good days” or brief periods of improved functioning do not negate the presence of significant, ongoing limitations. They can also clarify that attempts to remain socially engaged or to maintain some household roles are not inconsistent with disability from competitive, full-time employment.
Work capacity evaluations in FND should go beyond simple binary judgments of “fit” or “unfit” for work and instead consider graded capacity, reasonable accommodations, and the feasibility of supported or modified duties. An individual might be unable to perform heavy manual labor or operate dangerous machinery because of unpredictable functional weakness or seizures yet remain capable of part-time, flexible administrative work with adjustments for fatigue and concentration difficulties. Disability benefit systems vary in how they handle partial work capacity; some allow partial benefits or phased return-to-work programs, while others impose “all or nothing” thresholds. Detailed functional descriptions in medical reports can guide more nuanced decisions and help align benefit determinations with realistic vocational possibilities.
The process of application, review, and appeals for disability benefits can itself exacerbate symptoms in people with FND, as repeated assessments, perceived mistrust, and contested decisions increase stress and hypervigilance. Lengthy disputes over entitlement can reinforce an illness identity and detract from rehabilitation efforts by focusing attention on proving incapacity rather than building capacity. Clinicians involved in these processes can mitigate some of this harm by providing clear, consistent documentation; educating patients about likely timelines and requirements; and framing disability support as a means to stabilize the situation and facilitate engagement in treatment, rather than as an end in itself.
Differences between public disability programs and private insurance policies can significantly influence outcomes for claimants with FND. Public systems often use standardized impairment criteria, which may or may not explicitly mention FND or dissociative neurological symptom disorders. When such conditions are not specifically listed, claimants may be evaluated under generic categories such as “neurological disorders,” “epilepsy,” or “mental disorders,” each with its own evidentiary requirements. Private policies, in contrast, are governed by contract language that may include exclusions or limitations for conditions deemed “mental and nervous” or for disorders without demonstrable structural pathology. Disputes frequently arise over whether FND should be classified as a neurological disorder, a mental disorder, or both, with significant implications for the duration and amount of payable benefits.
Successful navigation of disability benefit systems for individuals with FND usually requires coordinated input from multiple professionals: neurologists, psychiatrists or psychologists, physiotherapists, occupational therapists, and sometimes vocational rehabilitation specialists. Each contributes distinct perspectives on functioning, treatment options, and workplace demands. Integrated reports that synthesize these perspectives into a coherent narrative of the person’s capacities and limitations tend to carry more weight than fragmented letters that offer narrow or conflicting opinions. This collaborative approach also mirrors best-practice clinical care, reinforcing the legitimacy of FND as a condition requiring multidisciplinary management rather than minimal or purely psychological intervention.
Insurance coverage disputes and claim denials
Insurance coverage disputes in the context of functional neurological disorder often arise at the intersection of clinical uncertainty, outdated policy language, and institutional skepticism toward conditions without obvious structural lesions. Insurers may question whether FND qualifies as a “medically necessary” condition warranting reimbursement for neurologist consultations, video-EEG monitoring, multidisciplinary rehabilitation, psychotherapy, or inpatient treatment. Policies that implicitly equate neurological disease with imaging abnormalities can be used to argue that services are “experimental,” “investigational,” or “not supported by objective findings,” despite contemporary evidence and guidelines supporting specific interventions for FND. These disputes are particularly common when claims involve prolonged or intensive rehabilitation programs, repeated hospitalizations for functional seizures, or combined physical and psychological therapies.
A recurrent point of contention is the classification of FND as a neurological versus a mental health condition for insurance purposes. Many benefit plans apply separate coverage limits, higher co-payments, or stricter session caps to mental health services, and some policies still contain outdated exclusions for “psychosomatic” or “somatoform” disorders. When insurers categorize FND as predominantly psychiatric, they may deny or restrict access to neurologic assessments, physiotherapy, or inpatient neurorehabilitation, contending that treatment should be provided solely under mental health benefits with limited scope. Conversely, when FND is recognized exclusively as a neurological condition, access to necessary psychological therapies may be constrained. Clinicians and legal advocates often need to emphasize that FND is best understood as a disorder of brain network functioning with both neurological and psychological dimensions, and that effective treatment typically requires integrated care across disciplines.
Coverage disputes also emerge around the requirement for “objective evidence” of disease. Some insurers interpret this phrase narrowly as the presence of abnormal imaging, electrophysiological findings, or laboratory results, and they may use normal MRI, CT, or EEG studies as grounds to deny claims for treatment or disability benefits. In FND, however, objective evidence frequently takes the form of positive bedside clinical signs, documented events on video-EEG without epileptic correlates, standardized functional assessments, or detailed descriptions of internal inconsistency and incongruence with recognized structural disorders. When medical records clearly describe these features, they can satisfy reasonable definitions of objectivity and counter the notion that FND is merely subjective or unverifiable. Absence of such documentation, by contrast, makes it easier for insurers to argue that there is insufficient proof of a qualifying condition.
Policy language concerning pre-existing conditions and causation can complicate insurance determinations for individuals with FND who experience symptom onset after an accident, surgery, or other insured event. Insurers may assert that FND represents a manifestation of longstanding psychological vulnerability or prior stress-related symptoms, thereby invoking exclusions for pre-existing mental health conditions. Claimants and clinicians may argue instead that the insured event materially triggered or exacerbated FND, even if latent vulnerabilities existed. Disputed questions include whether a mild head injury or whiplash without structural damage can reasonably lead to functional seizures or gait disorders, and whether intense workplace stress or harassment can be considered a precipitating factor. Expert reports that outline the biopsychosocial model of FND, including evidence that relatively minor physical or psychological insults can precipitate disabling symptoms in susceptible individuals, are often central in resolving these disagreements.
Another frequent area of conflict is the definition of “appropriate” or “standard” treatment. Insurers may agree that FND is a legitimate diagnosis but deny specific therapies as non-standard, particularly when they involve intensive, interdisciplinary programs or emerging modalities such as specialized FND physiotherapy protocols, virtual reality interventions, or specific psychotherapies. Some policies insist on stepwise treatment pathways, requiring demonstration of inadequate response to less costly, more generic approaches before authorizing specialized care. In practice, this can delay access to the very interventions with the best evidence for improving function and reducing healthcare utilization. Detailed treatment rationales, references to clinical guidelines, and documentation of prior failed or insufficient treatments can be essential in overturning such denials.
Insurance coverage disputes often turn on differences between acute and chronic care benefits. Short-term hospitalization for diagnostic clarification, such as video-EEG monitoring to distinguish functional from epileptic seizures, may be readily approved, whereas longer-term rehabilitation for chronic functional motor symptoms faces stricter scrutiny. Insurers may characterize ongoing rehabilitation as “custodial,” “maintenance,” or primarily supportive rather than restorative, and policies often exclude such services. Clinicians can counter this by clearly stating rehabilitative goals—such as improving gait stability, reducing seizure frequency, enhancing self-management strategies, or enabling return to modified work—and by tracking measurable progress over time. Documentation of functional gains, even if partial, helps demonstrate that treatment is active and medically necessary rather than purely palliative.
Mental health parity laws and anti-discrimination regulations in some jurisdictions provide tools to challenge restrictive coverage policies affecting people with FND. When insurers impose more stringent requirements, shorter duration limits, or lower reimbursement rates for interventions classified as mental health treatment compared with analogous medical or neurological services, they may violate parity standards. Legal advocates may use case law and regulatory guidance to argue that FND-related interventions should not be disadvantaged simply because they involve psychological components. Demonstrating that integrated neuropsychiatric or psychotherapeutic interventions are essential for restoring neurological function—and not optional adjuncts to “real” medical care—can support claims that parity obligations apply.
The appeals process is a critical avenue for contesting initial insurance denials, yet it can be arduous and time-sensitive. Many policies require internal appeals within strict deadlines, followed by external review or litigation if disputes persist. Successful appeals typically rely on comprehensive submissions that include updated clinical reports, clarification of diagnostic reasoning, literature references, and statements from treating providers regarding prognosis and risks of untreated FND. It is often necessary to address specific denial rationales in a structured manner—for example, by challenging assertions that there is “no objective evidence” with references to positive functional signs, or by contesting the claim that requested therapies are “experimental” through citation of consensus guidelines and peer-reviewed studies. Coordinated efforts among clinicians, patients, and legal representatives are usually more effective than piecemeal responses.
Surveillance and allegations of exaggeration or malingering occasionally feature in insurance coverage disputes involving FND, especially in high-value claims or long-term disability cases. Insurers may commission covert video recording or social media monitoring, then highlight instances in which the claimant appears to function better than described in medical reports. Without context, such material can be misinterpreted as proof of deception. Experts familiar with FND can explain that variability, task-specificity, and situational improvement are core characteristics of the disorder, not evidence against it. For example, a person with functional gait disorder may walk more fluidly when distracted in an unobserved setting yet struggle conspicuously when anxious, fatigued, or under scrutiny. Reframing these observations within the clinical understanding of FND can weaken the probative value attributed to surveillance footage.
Coordination between health insurers and other benefit systems, such as workers’ compensation or automobile injury schemes, introduces additional complexity. Disputes may concern which insurer is primarily responsible for covering care when FND develops after an occupational incident or motor vehicle accident, or whether responsibility should shift once acute injuries have healed but functional symptoms persist. Each system may attempt to shift costs to the other by characterizing FND as unrelated to the original event, purely psychiatric, or attributable to non-compensable stressors. Clear timelines of symptom onset, detailed accounts of the context in which symptoms first appeared, and consistent linkage of FND to the triggering event in the medical record can be crucial in establishing causal relationships that align with policy definitions.
Long-term disability insurance claims for individuals with FND frequently generate prolonged disputes over ongoing eligibility. Insurers may approve benefits initially, recognizing the severity of early symptoms, but later seek to terminate payments based on independent assessments suggesting improvement, reclassification of the condition as mental health–related with shorter maximum benefit periods, or assertions that the claimant can perform “any occupation.” Periodic reviews sometimes hinge on brief snapshot examinations that underestimate fluctuation, fatigue, and post-exertional symptom worsening. Robust, longitudinal documentation from treating clinicians, including detailed descriptions of good days and bad days, functional variability, and attempts at graded activity or return to work, is vital to counter abrupt benefit termination based on overly optimistic or incomplete assessments.
Disagreements also commonly arise over coverage for assistive devices, home modifications, and supportive services for people with severe, chronic FND. Insurers may view mobility aids, in-home support, or adaptive technologies as unjustified if neurological examinations show variable weakness or if there is hope of functional recovery. Advocates can argue that such supports reduce fall risk, enhance independence, and facilitate participation in rehabilitation, thereby potentially lowering long-term costs. In some systems, legal frameworks governing reasonable accommodation or disability rights can be invoked to support the provision of necessary equipment and services, especially when lack of support would effectively preclude work, education, or basic self-care.
Effective navigation of insurance coverage disputes in FND relies heavily on strategic, precise, and consistent medical documentation. Clinicians who clearly articulate the diagnosis using contemporary terminology, record positive signs and objective findings characteristic of FND, describe functional limitations in concrete terms, and explain rationales for specific treatments provide crucial support for their patients’ claims. Conversely, ambiguous phrases such as “medically unexplained” or “subjective complaints” without further clarification can inadvertently undermine coverage by giving the impression of diagnostic uncertainty or doubt about symptom legitimacy. Training clinicians in medico-legal communication and encouraging early consideration of potential insurance implications can reduce the likelihood of protracted disputes.
Ultimately, while policy terms and legal standards vary, many insurance coverage conflicts involving FND revolve around recurring themes: recognition of FND as a legitimate, disabling health condition; acceptance of positive functional signs as “objective evidence”; access to multidisciplinary treatment as medically necessary rather than optional; and fair application of mental health parity and disability rights principles. Systematic attention to these themes in clinical practice, advocacy, and legal argumentation can improve the chances that individuals with FND receive timely, appropriate, and sustained coverage for the care they need.
Workplace accommodations and employment protection
Employment protection for people with functional neurological disorders intersects with disability rights law, occupational health practice, and employer risk management. At its core, the law in many jurisdictions obliges employers to avoid discrimination on the basis of disability and to provide reasonable accommodations that enable qualified individuals to perform the essential functions of their jobs. Whether FND is explicitly named in legislation or not, its impact on motor function, cognition, seizure risk, fatigue, and reliability typically brings it within legal definitions of disability when symptoms substantially limit one or more major life activities or significantly restrict the ability to work. The absence of structural lesions on imaging does not diminish this protection; what matters legally is functional impact, not whether MRI or EEG abnormalities are present.
One of the most important steps in securing workplace accommodations is timely, clear medical certification that explains the diagnosis and its functional implications in language relevant to employment. Employers and human resources staff generally require documentation that addresses what tasks the employee can and cannot perform, under what conditions, and for how long, rather than detailed pathophysiological explanations. For example, a letter might state that an individual with functional seizures should not operate heavy machinery, climb ladders, or drive as part of their duties, or that an employee with a functional gait disorder may require a reduced walking distance, use of mobility aids, and avoidance of time-pressured physical tasks. When clinicians link these restrictions directly to job functions, it becomes easier for occupational health teams and managers to design specific modifications and to comply with disability accommodation obligations.
Reasonable accommodations for FND vary widely depending on the symptom profile and type of work. For individuals with functional seizures or episodic collapse, accommodations may include eliminating driving and safety-critical tasks, reassigning duties that involve heights or open water, providing a safe space where they can recover after episodes, and ensuring that colleagues are trained in basic first aid and know when emergency services are and are not required. Employees with functional weakness, tremor, or gait disturbance may benefit from ergonomic adjustments, sit-stand options, reassignment of manual handling duties, closer parking, relocation to a ground-floor office, or flexibility to use mobility aids. Those with functional cognitive symptoms might require reduced multitasking, written instructions, checklists, structured breaks, quiet workspaces, or software tools that aid memory and organization. Flexible scheduling, part-time hours, or remote work arrangements can be critical for managing fatigue and fluctuating symptoms.
Employers are not usually required to provide accommodations that impose an “undue hardship,” such as disproportionate cost or significant disruption to operations. However, what counts as undue hardship is often interpreted narrowly, particularly for larger organizations with substantial resources. Many adjustments for FND—altered start times, brief rest breaks, task reallocation within a team, or modest ergonomic purchases—are low-cost and logistically straightforward. Documentation from clinicians that outlines practical, evidence-informed modifications and emphasizes their likely benefits for attendance, safety, and productivity can help employers recognize that accommodations are feasible rather than burdensome. Conversely, recommendations that are very broad or vague, such as “avoid all stress” or “must never use a computer,” may be difficult to implement and more likely to be contested.
A common challenge in FND is that symptoms fluctuate, producing good days and bad days, and may improve or worsen over time with treatment, stress, and environmental demands. Workplaces often prefer clear, stable restrictions; they may struggle with episodic incapacity, short-notice absences, and variable performance. To manage this, a graded return-to-work plan or staged accommodation strategy is often effective. Such plans may start with a small number of hours per week, limited tasks, and generous rest breaks, with scheduled reviews to increase responsibilities as tolerated. When clinicians and occupational health practitioners provide specific milestones—for example, increasing from three to five half-days over six weeks if seizure frequency decreases—employers have a framework for planning staffing while maintaining flexibility. Importantly, the possibility of improvement with rehabilitation should not be used to deny current accommodations; the legal focus is on present functional capacity, with regular reassessment as conditions change.
Disclosure of FND to an employer is typically voluntary, but employees must usually share enough health information to justify accommodations and sick leave. Many individuals are understandably reluctant to disclose due to stigma, fear of job loss, or prior negative experiences where symptoms were dismissed as “all in the mind.” Clinicians can support informed decision-making by explaining what information is necessary for employers and by framing FND as a recognized neurological condition with established treatment pathways. When employees choose to disclose, it is often helpful for documentation to emphasize that symptoms are genuine and involuntary, outline objective findings such as positive functional signs or video-EEG evidence, and avoid language that might be misinterpreted as malingering or purely psychological weakness. This can preempt skepticism and reduce the risk that colleagues or supervisors misjudge fluctuating performance.
Occupational health services play a pivotal role in translating medical information into concrete workplace actions. Occupational physicians or nurses can conduct independent assessments of functional capacity, review job descriptions, and recommend specific accommodations. In cases of FND, they should be aware that internal inconsistency and distractibility of symptoms are characteristic features, not signs of deception. Their reports to employers should focus on risk management and job matching—assessing, for instance, whether an employee with functional seizures can safely work in a role that does not involve driving, heights, or unsupervised work with vulnerable individuals. When occupational health services work collaboratively with treating clinicians, sharing information (with the employee’s consent) and aligning recommendations, employers receive consistent guidance, which can reduce conflict and confusion.
Safety-sensitive roles require particular scrutiny. Professions such as commercial driving, aviation, rail operations, law enforcement, firefighting, and certain healthcare roles impose strict medical fitness standards because episodic loss of consciousness, sudden weakness, or altered awareness can have catastrophic consequences. Regulatory bodies or licensing authorities may have specific rules regarding seizures and other neurological events; these often do not explicitly address functional seizures, leaving room for interpretation. In practice, regulators and employers typically treat any seizure-like episodes that cause abrupt loss of control as relevant, irrespective of whether they are epileptic or functional. As a result, employees with FND may face temporary or longer-term restrictions from safety-critical duties. Clear documentation of seizure patterns, triggers, responsiveness to treatment, and duration of any recommended restriction period is important for licensing decisions and for structuring redeployment to non-safety-sensitive work where feasible.
When an employee with FND cannot continue in their original role despite accommodations, laws in many jurisdictions encourage or require consideration of reassignment to a vacant, suitable alternative position. For example, a bus driver with frequent functional seizures might be redeployed to a depot-based administrative role; a nurse with unpredictable functional weakness may transition to an educational or advisory position with minimal manual handling. Employers must typically consider the employee’s skills, qualifications, and retraining potential. Documentation that identifies realistic alternative duties, along with information about the likely stability of functioning in those roles, can support redeployment rather than termination. Where redeployment is not possible or would constitute undue hardship, termination of employment may still occur, but this is more legally defensible if a documented process of considering accommodations and alternative roles has been followed.
Attendance management policies can generate tension in FND, where intermittent exacerbations and medical appointments may increase absences. Strict “no-fault” absence policies that trigger disciplinary steps after a fixed number of days off can indirectly discriminate against employees with chronic health conditions. Disability law often requires employers to modify or flexibly apply such policies as a form of reasonable accommodation, for example by discounting medically verified absences related to a disability or by allowing intermittent leave. Clinicians can help by specifying anticipated frequency of flare-ups or appointments, and by providing updated notes when patterns change. Employers should also recognize that supporting treatment and rehabilitation—through schedule flexibility or short-term leave—can reduce long-term absences by improving symptom control and work capacity.
Workplace culture and managerial attitudes significantly influence whether accommodations for FND are successful. Even where formal adjustments exist on paper, unsympathetic supervisors, peer resentment, or misunderstanding of the condition can undermine implementation. Employees may feel pressured to work through severe symptoms, hide episodes, or exceed agreed limitations to avoid appearing unreliable, which can worsen their health and ultimately reduce productivity. Training managers and human resources personnel about invisible disabilities, fluctuating conditions, and specifically about FND where relevant can foster a more supportive environment. Emphasizing that accommodations are legal rights rather than special favors, and that they often enhance team performance by retaining skilled staff, can reduce resentment and encourage creative problem-solving.
Disputes over accommodation often arise when an employer questions the legitimacy of the condition, the necessity of requested adjustments, or the feasibility of continued employment. These conflicts may involve formal grievances, union representation, or legal complaints to equality or labor tribunals. In such contexts, contemporaneous medical documentation and detailed occupational health reports become central evidence. They should describe the evolution of symptoms, prior attempts at accommodation, objective findings supporting the diagnosis, and the reasoning behind any work restrictions. Where employers have failed to engage in an interactive accommodation process—such as by refusing to consider alternative duties or declining to discuss flexible scheduling—labor or human rights bodies may view this as evidence of discrimination, regardless of whether the original dismissal or disciplinary action could have been justified with better process.
Return-to-work after a period of sickness absence due to FND can be both therapeutically beneficial and legally complex. From a rehabilitation perspective, graded re-engagement with meaningful activity is often recommended, as long-term absence can reinforce disability beliefs and social isolation. Yet premature or poorly structured return can precipitate relapse, job loss, or workplace accidents. A coordinated plan involving the employee, treating clinicians, occupational health, and the employer is generally optimal. This plan should clarify current limitations, specify any temporary versus permanent restrictions, outline monitoring mechanisms, and set review dates to adjust the plan as needed. Where income replacement or disability insurance benefits are in place, insurers may also require input into return-to-work arrangements; their desire to reduce benefit payments must be balanced against the risk of forcing an unsafe or unsustainable resumption of duties.
In some cases, disputes about accommodations intersect with entitlement to disability benefits or workers’ compensation. For example, an employer might argue that an employee with FND is “fit for suitable alternative duties” and therefore should no longer receive wage-replacement benefits, while the employee and their treating team maintain that symptom unpredictability and environmental triggers make consistent attendance impossible. Disentangling these issues requires careful functional assessment—sometimes through formal functional capacity evaluations—and alignment between medical opinions provided to employers, insurers, and government disability agencies. Inconsistencies in documentation across these systems can be seized upon by employers or insurers to challenge credibility; conversely, coherent, well-justified restrictions and work recommendations strengthen both workplace accommodation claims and disability benefit applications.
Legal protections against harassment and victimization are relevant where employees with FND experience ridicule, disbelief, or punitive treatment because of their symptoms. Colleagues may misinterpret functional seizures or gait disturbances as dramatization, or resent schedule changes and perceive them as favoritism. Employers are usually obligated to address such behavior once notified, through policy enforcement, training, and, where necessary, disciplinary action. Failure to do so can expose the organization to liability for a hostile work environment in addition to disability discrimination. Clear internal policies, reporting mechanisms, and leadership messaging that affirms the legitimacy of neurological and mental health conditions alike are crucial in preventing escalation and in demonstrating compliance if disputes proceed to legal forums.
Employment contracts, collective bargaining agreements, and sector-specific regulations may impose additional rights or constraints concerning fitness for duty, redeployment, and medical retirement. For instance, some public safety or transportation roles include mandatory medical retirement provisions when certain functional thresholds are crossed, while others provide income protection or retraining funds. Employees with FND and their advisors should review these instruments carefully in parallel with general disability law. Strategic use of available benefits—such as temporary disability pensions, vocational rehabilitation funding, or education allowances—can support long-term vocational outcomes, whether within the same employer or through transition to new work better matched to the individual’s abilities and health trajectory.
Risk management, documentation, and expert testimony
Risk management in functional neurological disorders requires early recognition that symptoms may intersect with legal, insurance, and safety issues. Clinicians should routinely consider how episodes of functional seizures, sudden collapses, functional weakness, or visual disturbances might affect driving, occupational safety, parenting responsibilities, or other risk-sensitive domains. Asking targeted questions about the person’s typical day, their job tasks, caring responsibilities, and situations in which symptoms have caused harm or near-misses helps to identify areas where explicit advice, restrictions, or supports are needed. Failure to address these questions can leave both the patient and the clinician vulnerable in subsequent inquiries about avoidable accidents, unsafe return to work, or alleged negligence.
Clear, contemporaneous documentation is the central tool for managing these risks. Clinical notes should record not only diagnostic reasoning and positive functional signs but also discussions about safety, driving, employment limitations, and treatment recommendations. For instance, if a person with frequent functional seizures is advised not to drive or to avoid operating machinery, this advice should be documented verbatim, with the date and the patient’s response. Similarly, if the clinician concludes that no restriction is currently required in a particular domain, the rationale for that decision should be noted. When regulators, insurers, or courts review the record months or years later, well-structured documentation can demonstrate that foreseeable risks were assessed and that reasonable steps were taken to mitigate them.
When symptoms pose acute risk—such as repeated uncontrolled collapses, intense functional movements with injury potential, or episodes that resemble loss of awareness—risk management may involve short-term activity restrictions, supervision, or even brief hospital admission. The reasoning behind these decisions should be explicit: whether the concern is direct physical harm (for example, falling down stairs), risk to others (such as dropping an infant during an episode), or secondary harms like unnecessary emergency service use. As symptoms stabilize and self-management improves, restrictions can often be relaxed, but incremental changes should be recorded, with reference to observed progress or new information. This chronological narrative of risk evaluation and modification is often highly relevant in later disability, insurance, or licensing proceedings.
Driving is frequently a focal point of medico-legal scrutiny in FND, especially in individuals with functional seizures, dissociative episodes, or sudden motor interruptions. Many jurisdictions have explicit reporting or counseling requirements when a clinician becomes aware of seizure-like events that could impair driving safety. Even where the law is silent about FND specifically, it is usually interpreted to encompass any involuntary episodes that could compromise control of a vehicle. Clinicians should familiarize themselves with local guidelines and apply them consistently, focusing on practical risk: whether events are sudden, unpredictable, and associated with impaired awareness or control. Documentation should specify whether advice not to drive was given, whether authorities were notified (if required), and under what conditions driving might resume, such as a defined seizure-free period or adequate symptom control.
Risk management also intersects with the design and supervision of treatment plans. Interventions that may temporarily destabilize symptoms—such as exposure-based therapies, intensive physiotherapy, or medication changes—should be accompanied by clear anticipatory guidance about risk. Patients should be advised, for example, to avoid new high-risk activities during the early stages of treatment and to seek help promptly if episodes intensify in ways that increase injury potential. Clinicians should record that these discussions took place and that consent was obtained, including acknowledgment of known uncertainties. When later questioned about whether a particular therapy “caused” a fall, accident, or work incident, detailed records of informed planning and risk mitigation can be crucial in demonstrating that the intervention was reasonable and appropriately managed.
In addition to managing physical risks, clinicians should consider psychological and social risks that carry legal or occupational implications. Persistent invalidation, repeated negative investigations, and adversarial disputes over benefits can exacerbate distress, suicidal ideation, or self-harm behaviors in some people with FND. When such risks are identified, they should be evaluated using standard mental health frameworks, with clear documentation of risk factors, protective factors, safety plans, and referrals. This does not mean pathologizing all distress, but rather recognizing that serious mental health crises can co-occur with FND, and that failure to address them may later be scrutinized as a missed opportunity to prevent harm.
High-quality clinical records serve multiple, overlapping functions beyond immediate care: they support continuity between providers, inform occupational health decisions, provide evidence for disability claims, and form the backbone of any subsequent expert testimony. To fulfill these roles, documentation should go beyond simple labels and symptom lists. It should specify the positive signs supporting the diagnosis, such as Hoover’s sign in functional weakness, variability of tremor with distraction, or typical semiology of functional seizures on video-EEG. It should also record functional impact in concrete terms—for instance, “episodes occurring several times per week leading to sudden collapse, requiring assistance to stand; unable to safely climb ladders or work at unprotected heights.” These details help third parties understand why symptoms are disabling or risky even in the absence of structural lesions.
Language choice in documentation is particularly important in FND and has direct medico-legal implications. Phrases such as “all in the mind,” “no neurological disease,” or “only functional” can be misinterpreted by non-specialists as implying that symptoms are fictitious or trivial. Conversely, vague terms like “medically unexplained” without explanation of positive functional signs may create confusion about diagnostic certainty. Using precise phrases such as “functional neurological disorder with positive signs of internal inconsistency,” “functional seizures with video-EEG confirmation and no epileptiform correlate,” or “functional gait disorder incongruent with known structural pathology” conveys that the diagnosis is evidence-based and recognized. When disputes arise—for example, in insurance appeals or employment tribunals—such wording can prevent mischaracterization of the condition as mere subjective complaint.
Internal consistency of the medical record across providers is another core risk management issue. In complex cases involving neurologists, psychiatrists, psychologists, physiotherapists, and primary care clinicians, inconsistent formulations or conflicting diagnoses are common. One note might refer to “conversion disorder,” another to “non-epileptic attacks,” and a third to “unexplained seizures, possible feigning.” These discrepancies can be exploited in adversarial contexts to cast doubt on the legitimacy of the symptoms or to deny benefits. Multidisciplinary teams should therefore aim for a shared formulation, a unified primary diagnosis where appropriate, and transparent acknowledgment of remaining uncertainties. Summative letters that reconcile differing perspectives and clarify the working diagnosis help reduce the risk that fragmented documentation will undermine the patient’s position in legal or administrative proceedings.
When clinicians anticipate the possibility of future legal scrutiny—such as in the context of workplace injuries, road traffic accidents, or contentious disability claims—they should be particularly careful to separate factual observations from speculation and to avoid pejorative language. Notes should distinguish between observed behaviors, patient self-report, and professional opinion. For example, instead of documenting “patient exaggerates symptoms,” it is preferable to state, “symptom report on questionnaire more severe than observed function during examination; pattern consistent with functional neurological disorder where variability and context dependence are characteristic.” This kind of phrasing maintains clinical accuracy without implying deception and is more defensible if later cross-examined.
Expert testimony in FND-related cases requires a distinct shift from routine clinical communication to structured, legally oriented analysis. Experts must be clear about their role: to assist the court or tribunal by providing impartial, evidence-based opinions, rather than to advocate for one party. This impartiality should be stated explicitly in written reports and maintained throughout testimony. Experts should explain the nature of FND in accessible language, avoiding jargon where possible while accurately conveying that symptoms are involuntary, arise from disordered brain functioning, and are diagnosed on the basis of positive signs rather than simple exclusion. They should set out the relevant diagnostic criteria (for example, DSM-5-TR or ICD-11), map the case facts onto these criteria, and explain the reasoning process that led to the diagnosis.
When preparing an expert report, it is essential to methodically review all available records, including emergency notes, outpatient letters, imaging and EEG reports, therapy records, occupational health assessments, and prior medico-legal opinions. The expert should summarize this material, highlight key consistencies or discrepancies, and indicate which sources carry the most weight. For instance, a video-EEG study capturing typical seizure-like events without epileptiform activity may be highly probative, as may longitudinal physiotherapy notes documenting reproducible functional signs. The report should also note any limitations, such as missing data, short assessment duration, language barriers, or possible secondary gain factors, while resisting the temptation to over-interpret these gaps as evidence of malingering in the absence of clear indicators.
Courts and tribunals frequently ask experts to address specific questions: Is the diagnosis of FND more likely than not correct? Were symptoms caused or materially contributed to by a particular event, such as a minor head injury or workplace stressor? To what extent do FND symptoms limit the person’s ability to work, drive, or carry out daily activities? What is the likely prognosis, and what treatment is reasonable? Experts should respond to each question separately and clearly, indicating when an issue lies outside their expertise. They should use the applicable legal standard of proof—typically the “balance of probabilities” in civil cases—rather than demanding scientific certainty. Where evidence is insufficient to reach a firm conclusion, this should be stated frankly, with an explanation of what additional information might alter the opinion.
A recurring challenge in expert testimony is the need to differentiate FND from malingering or factitious disorder without conflating them. Legal teams may press the expert to opine on credibility or to declare whether symptoms are “genuine” or “faked.” It is important to explain that FND is, by definition, an involuntary condition, and that the presence of positive functional signs argues against deliberate feigning. At the same time, experts should acknowledge that malingering can occasionally coexist with genuine FND, just as in other disorders. Where there are specific red flags for intentional deception—such as clear external incentives combined with inconsistent accounts, tampering with tests, or contradictory surveillance evidence—these should be described carefully, with citation to the underlying data, rather than inferred from variability alone. This nuanced approach both respects the science and helps courts avoid unjust conclusions based on stereotypes.
Experts may also be asked to comment on causation in complex sequences of events, such as whether a low-impact collision or workplace incident “caused” FND in a person with prior anxiety or somatic symptoms. In these situations, it can be helpful to explain the biopsychosocial model of FND, emphasizing that pre-existing vulnerabilities and acute triggers often interact. The legal question is usually not whether the event was the sole cause but whether it made a material contribution to the onset or worsening of symptoms. Experts can outline plausible mechanisms—for example, how acute pain, fear, and heightened bodily attention during an accident could activate networks involved in motor control and perception in a susceptible brain—while also acknowledging that individual susceptibility cannot always be predicted. Clear explanation of this framework helps adjudicators move beyond simplistic “all or nothing” views of causation.
In disability, workers’ compensation, or personal injury litigation, experts are often required to provide opinions about functional capacity and work prospects. They should distinguish between diagnosis (is FND present?) and impairment (what the person can and cannot reliably do), and between current status and future prognosis. Where possible, opinions should reference objective or semi-objective measures, such as functional capacity evaluations, standardized scales, or detailed observational reports, while recognizing their limitations in a fluctuating disorder. Statements like “can sit for up to 30 minutes but requires short breaks thereafter” or “unpredictable seizure-like episodes averaging three times per week, limiting ability to perform safety-sensitive tasks or maintain consistent attendance” are more helpful than broad assertions of total incapacity or full fitness.
The process of giving oral evidence can be adversarial, with cross-examination focusing on perceived inconsistencies, gaps in the literature, or minor variations in the patient’s presentation across time. Experts should remain grounded in the available evidence and their documented report, avoiding speculation or advocacy. When confronted with surveillance footage or isolated records that appear inconsistent with the diagnosis, they can explain how variability, context, and attention effects are intrinsic to FND. For example, an individual might appear to walk normally in a brief segment of informal video yet display pronounced gait disturbance when anxious or under examination. By situating such material within the broader clinical context, experts can help courts avoid overvaluing isolated observations while still acknowledging that the evidence merits consideration.
Ethical obligations in expert work mirror those in clinical practice but are framed in relation to the court or tribunal rather than to the individual patient or claimant. Experts must declare conflicts of interest, including prior involvement in the case, relationships with insurers or law firms, and financial interests that could be perceived as influencing their views. They should also avoid taking on roles that create dual obligations likely to conflict—for example, serving simultaneously as a treating clinician and an independent expert witness in the same legal matter, unless jurisdictional rules and professional standards explicitly permit it and potential conflicts are openly managed. Transparency about role, limits of knowledge, and sources of information enhances the credibility of the expert and reduces medico-legal risk.
Risk management in FND is a collective endeavor that extends beyond individual clinicians and experts to institutions and systems. Hospitals, rehabilitation centers, and specialty clinics can reduce medico-legal exposure by developing clear care pathways, written protocols for the assessment and management of functional seizures and other FND presentations, and staff training that emphasizes positive diagnostic criteria and non-stigmatizing communication. Standardized templates for clinic letters and reports can prompt clinicians to address key medico-legal issues—such as driving, work capacity, and safety risks—systematically rather than ad hoc. When disputes about benefits, insurance coverage, or workplace accommodations arise, institutions with robust, consistent documentation and clear protocols are better positioned to support their patients and to withstand external scrutiny.
